Characteristics and cross-resistance patterns of chloroquine-resistant Plasmodium berghei infections in mice.
D000655:Amodiaquine / Q000627:therapeutic use; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000494:pharmacology* / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005260:Female; D006400:Hematocrit; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008288:Malaria / Q000097:blood / Q000188:drug therapy; D051379:Mice; D009929:Organ Size; D010961:Plasmodium / Q000187:drug effects* / Q000302:isolation & purification; D011319:Primaquine / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D012376:Rodent Diseases; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis; D013154:Spleen / Q000473:pathology; D013163:Splenomegaly / Q000209:etiology; D013411:Sulfadiazine / Q000627:therapeutic use
D000962:Antimalarials; D007527:Isoenzymes; D012709:Serum Albumin; D012712:Serum Globulins; D013411:Sulfadiazine; D000655:Amodiaquine; D002738:Chloroquine; D003622:Dapsone; D011803:Quinine; D007770:L-Lactate Dehydrogenase; D011796:Quinacrine; D011319:Primaquine; D011739:Pyrimethamine